{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:45:18Z","timestamp":1765781118020,"version":"3.48.0"},"reference-count":29,"publisher":"CSIRO Publishing","issue":"2","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":1265,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To support improving participation in the National Bowel Cancer Screening Program (NBCSP), we aimed to identify Medicare-subsidised test requests for immunochemical faecal occult blood tests (FOBT) in Australian general practice for patients aged 50\u201374 years, eligible for the NBCSP, and describe sociodemographics, risk factors, indications and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted using de-identified data from 441 Australian general practice sites in the MedicineInsight database, recorded from 1 January 2018 to 31 December 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 683 625 eligible patients, 45 771 (6.7%) had a record of a general practitioner (GP)-requested FOBT, either to aid diagnosis in symptomatic patients, or for screening; 144 986 (21.2%) patients had only an NBCSP FOBT. A diagnosis of polyps, gastrointestinal inflammatory condition or haemorrhoids, or a referral to a gastroenterologist or general surgeon, was more commonly recorded in the 6 months after a GP-requested FOBT than after an NBCSP FOBT. Uptake of NBCSP FOBTs was lower among those with obesity, high alcohol consumption and current smokers, who are at higher risk of bowel cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study describes the patient characteristics, reasons and outcomes associated with GP-requested FOBTs, identifies under-screened population sub-groups, and suggests involvement of GPs to improve participation in the NBCSP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/ah21129","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T22:58:33Z","timestamp":1646002713000},"page":"222-232","source":"Crossref","is-referenced-by-count":1,"title":["Characteristics of patients aged 50\u201374 years with a request for an immunochemical faecal occult blood test in the Australian general practice setting"],"prefix":"10.1071","volume":"46","author":[{"given":"Allan","family":"Pollack","sequence":"first","affiliation":[{"name":"ANPS MedicineWise, Sydney, NSW 2010, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen","family":"Busingye","sequence":"additional","affiliation":[{"name":"ANPS MedicineWise, Sydney, NSW 2010, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Thistlethwaite","sequence":"additional","affiliation":[{"name":"ANPS MedicineWise, Sydney, NSW 2010, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Blogg","sequence":"additional","affiliation":[{"name":"ANPS MedicineWise, Sydney, NSW 2010, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendal","family":"Chidwick","sequence":"additional","affiliation":[{"name":"ANPS MedicineWise, Sydney, NSW 2010, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"2025121501415814900_R1"},{"key":"2025121501415814900_R2"},{"key":"2025121501415814900_R3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5694\/j.1326-5377.2007.tb00904.x","article-title":"Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals.","volume":"186","author":"Morris","year":"2007","journal-title":"Med J Aust"},{"key":"2025121501415814900_R4"},{"key":"2025121501415814900_R5"},{"key":"2025121501415814900_R6"},{"key":"2025121501415814900_R7","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1016\/S2468-2667(17)30105-6","article-title":"Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.","volume":"2","author":"Lew","year":"2017","journal-title":"Lancet Public Health"},{"key":"2025121501415814900_R8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4066\/AMJ.2013.1808","article-title":"Self-reported bowel screening rates in older Australians and the implications for public health screening programs.","volume":"6","author":"Zajac","year":"2013","journal-title":"Australas Med J"},{"key":"2025121501415814900_R9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.31128\/AJGP-01-18-4472","article-title":"Colorectal cancer screening in Australia: an update.","volume":"47","author":"Parkin","year":"2018","journal-title":"Aust J Gen Pract"},{"key":"2025121501415814900_R10"},{"key":"2025121501415814900_R11"},{"key":"2025121501415814900_R12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ijc.31314","article-title":"Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.","volume":"143","author":"Lew","year":"2018","journal-title":"Int J Cancer"},{"key":"2025121501415814900_R13","doi-asserted-by":"publisher","DOI":"10.17061\/phrp2921913","article-title":"Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.","volume":"29","author":"Lew","year":"2019","journal-title":"Public Health Res Pract"},{"key":"2025121501415814900_R14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227899","article-title":"Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.","volume":"15","author":"Worthington","year":"2020","journal-title":"PLoS One"},{"key":"2025121501415814900_R15","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1093\/ije\/dyz147","article-title":"Data Resource Profile: MedicineInsight, an Australian national primary health care database.","volume":"48","author":"Busingye","year":"2019","journal-title":"Int J Epidemiol"},{"key":"2025121501415814900_R16"},{"key":"2025121501415814900_R17"},{"key":"2025121501415814900_R18"},{"key":"2025121501415814900_R19"},{"key":"2025121501415814900_R20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1053\/j.gastro.2016.09.003","article-title":"Lifestyle risk factors for serrated colorectal polyps: a systematic review and meta-analysis.","volume":"152","author":"Bailie","year":"2017","journal-title":"Gastroenterology"},{"key":"2025121501415814900_R21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/1753-6405.12471","article-title":"Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions.","volume":"39","author":"Whiteman","year":"2015","journal-title":"Aust N Z J Public Health"},{"key":"2025121501415814900_R22"},{"key":"2025121501415814900_R23"},{"key":"2025121501415814900_R24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1258\/096914104774061074","article-title":"Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?","volume":"11","author":"Otto","year":"2004","journal-title":"J Med Screen"},{"key":"2025121501415814900_R25","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/aje\/kwk075","article-title":"Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial.","volume":"165","author":"Pinsky","year":"2007","journal-title":"Am J Epidemiol"},{"key":"2025121501415814900_R26"},{"key":"2025121501415814900_R27"},{"key":"2025121501415814900_R28","article-title":"Increasing bowel cancer screening participation: integrating population-wide, primary care and more targeted approaches.","volume":"29","author":"Lofti-Jam","year":"2019","journal-title":"Public Health Res Pract"},{"key":"2025121501415814900_R29"}],"container-title":["Australian Health Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/ah\/article-pdf\/46\/2\/222\/699914\/ah21129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/ah\/article-pdf\/46\/2\/222\/699914\/ah21129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:42:05Z","timestamp":1765780925000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/ah\/article\/46\/2\/222\/86903\/Characteristics-of-patients-aged-50-74-years-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4,7]]}},"URL":"https:\/\/doi.org\/10.1071\/ah21129","relation":{},"ISSN":["0156-5788","1449-8944"],"issn-type":[{"type":"print","value":"0156-5788"},{"type":"electronic","value":"1449-8944"}],"subject":[],"published":{"date-parts":[[2022,2,28]]}}}